Oligometastatic esophagogastric cancer (OMEC-4) paper summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter:
“Oligometastatic esophagogastric cancer (OMEC-4):
Definition:
- One organ with ≤3 metastases
- One extra-regional lymph node station
- Initially OM and without progression in number of metastases after systemic therapy
Staging:
- PET/CT imaging is recommended for basal staging and for restaging after systemic therapy
Treatment:
- Synchronous OM or metachronous OM and a DFI ≤2 years: systemic therapy followed by restaging and local therapy
- Metachronous OMD and DFI >2: upfront local therapy”
Read further.
Source: Erman Akkus/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.